Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 39.66% is 210% above its 5-year average of -36.08%, near the high end of its 5-year range (-63.02%–39.66%).
As of the fiscal period ended Tuesday, June 30, 2026. 2087.31% above its 12-month average of 1.81%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 39.66%.
RETURN ON EQUITY (ROE)
39.66%
RETURN ON EQUITY (ROE) AVG TTM
1.81%
RETURN ON EQUITY (ROE) AVG 3Y
-17.32%
RETURN ON EQUITY (ROE) AVG 5Y
-36.08%
RETURN ON EQUITY (ROE) AVG 10Y
-46.25%
RETURN ON EQUITY (ROE) AVG 15Y
-44.04%
RETURN ON EQUITY (ROE) AVG 20Y
-44.74%
CURRENT VS TTM AVG
+2087.31%
CURRENT VS 3Y AVG
+329.02%
CURRENT VS 5Y AVG
+209.92%
CURRENT VS 10Y AVG
+185.74%
CURRENT VS 15Y AVG
+190.06%
CURRENT VS 20Y AVG
+188.65%
SECTOR MEDIAN · HEALTHCARE
-40.40%
median of 667 covered companies
CURRENT VS SECTOR MEDIAN
+198.17%
vs the sector median at left
Compugen Ltd.
Market Cap
$211.33M
Return on Equity (ROE)
39.66%
TTM Avg
1.81%
3Y Avg
-17.32%
5Y Avg
-36.08%
Market Cap
$209.14M
Return on Equity (ROE)
-36.64%
TTM Avg
6.57%
3Y Avg
27.96%
5Y Avg
27.96%
Market Cap
$213.50M
Return on Equity (ROE)
-45.23%
TTM Avg
-120.85%
3Y Avg
-88.04%
5Y Avg
-69.68%
Market Cap
$208.02M
Return on Equity (ROE)
N/A
TTM Avg
620.74%
3Y Avg
332.27%
5Y Avg
266.26%
Market Cap
$214.64M
Return on Equity (ROE)
19.38%
TTM Avg
20.63%
3Y Avg
-8.44%
5Y Avg
-40.10%
Market Cap
$205.93M
Return on Equity (ROE)
28.68%
TTM Avg
26.59%
3Y Avg
20.62%
5Y Avg
19.74%
Market Cap
$213.72M
Return on Equity (ROE)
N/A
TTM Avg
-280.12%
3Y Avg
-179.90%
5Y Avg
-133.80%
Market Cap
$214.85M
Return on Equity (ROE)
21.24%
TTM Avg
17.52%
3Y Avg
32.51%
5Y Avg
46.01%
Market Cap
$218.46M
Return on Equity (ROE)
-106.27%
TTM Avg
-100.08%
3Y Avg
-64.49%
5Y Avg
-52.22%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Compugen Ltd. (CGEN) | $211.33M | 39.66% | 1.81% | -17.32% | -36.08% |
| Sionna Therapeutics, Inc. (SION)vs › | $209.14M | -36.64% | 6.57% | 27.96% | 27.96% |
| Prelude Therapeutics Incorporated (PRLD)vs › | $213.50M | -45.23% | -120.85% | -88.04% | -69.68% |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $208.02M | N/A | 620.74% | 332.27% | 266.26% |
| Niagen Bioscience Inc (NAGE)vs › | $214.64M | 19.38% | 20.63% | -8.44% | -40.10% |
| Pro-Dex, Inc. (PDEX)vs › | $205.93M | 28.68% | 26.59% | 20.62% | 19.74% |
| Alector, Inc. (ALEC)vs › | $213.72M | N/A | -280.12% | -179.90% | -133.80% |
| Anbio Biotechnology Class A Ordinary Shares (NNNN)vs › | $214.85M | 21.24% | 17.52% | 32.51% | 46.01% |
| Lyell Immunopharma, Inc. (LYEL)vs › | $218.46M | -106.27% | -100.08% | -64.49% | -52.22% |
| Electra Therapeutics Inc. (ETRA)vs › | $203.22M | N/A | N/A | N/A | N/A |
ROE
39.7%
ROA
25.4%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 39.66% |
| 2026-03-31 | 36.55% |
| 2025-12-31 | 34.40% |
| 2025-09-30 | -63.02% |
| 2025-06-30 | -38.53% |
| 2025-03-31 | -24.77% |
| 2024-12-31 | -25.92% |
| 2024-09-30 | 2.64% |
| 2024-06-30 | -16.33% |
| 2024-03-31 | -27.95% |
| 2023-12-31 | -28.61% |
| 2023-09-30 | -59.29% |
| 2023-06-30 | -53.96% |
| 2023-03-31 | -48.14% |
| 2022-12-31 | -43.38% |
| 2022-09-30 | -49.17% |
| 2022-06-30 | -37.24% |
| 2022-03-31 | -34.65% |
| 2021-12-31 | -32.06% |
| 2021-09-30 | -34.53% |
| 2021-06-30 | -34.54% |
| 2021-03-31 | -29.29% |
| 2020-12-31 | -24.79% |
| 2020-09-30 | -21.69% |
| 2020-06-30 | -20.33% |
| 2020-03-31 | -22.83% |
| 2019-12-31 | -71.34% |
| 2019-09-30 | -72.32% |
| 2019-06-30 | -84.59% |
| 2019-03-31 | -93.48% |
| 2018-12-31 | -60.68% |
| 2018-09-30 | -58.98% |
| 2018-06-30 | -72.19% |
| 2018-03-31 | -92.93% |
| 2017-12-31 | -126.52% |
| 2017-09-30 | -95.39% |
| 2017-06-30 | -72.33% |
| 2017-03-31 | -56.68% |
| 2016-12-31 | -49.60% |
| 2016-09-30 | -33.38% |
| 2016-06-30 | -29.10% |
| 2016-03-31 | -27.29% |
| 2015-12-31 | -22.43% |
| 2015-09-30 | -23.68% |
| 2015-06-30 | -20.78% |
| 2015-03-31 | -15.19% |
| 2014-12-31 | -10.47% |
| 2014-09-30 | -11.80% |
| 2014-06-30 | -12.11% |
| 2014-03-31 | -12.61% |
| 2013-12-31 | -44.16% |
| 2013-09-30 | -61.15% |
| 2013-06-30 | -73.84% |
| 2013-03-31 | -59.22% |
| 2012-12-31 | -77.12% |
| 2012-09-30 | -67.45% |
| 2012-06-30 | -58.02% |
| 2012-03-31 | -66.92% |
| 2011-12-31 | -61.30% |
| 2011-09-30 | -43.54% |
| 2011-06-30 | -29.59% |
| 2011-03-31 | -23.72% |
| 2010-12-31 | -25.47% |
| 2010-09-30 | -26.92% |
| 2010-06-30 | -28.51% |
| 2010-03-31 | -14.84% |
| 2009-12-31 | -13.98% |
| 2009-09-30 | -59.27% |
| 2009-06-30 | -63.92% |
| 2009-03-31 | -138.46% |
| 2008-12-31 | -125.23% |
| 2008-09-30 | -74.66% |
| 2008-06-30 | -67.33% |
| 2008-03-31 | -67.09% |
| 2007-12-31 | -70.08% |
| 2007-09-30 | -64.01% |
| 2007-06-30 | -58.56% |
| 2007-03-31 | -55.29% |
| 2006-12-31 | -50.59% |
| 2006-09-30 | -39.82% |
| 2006-06-30 | -41.03% |
| 2006-03-31 | -36.58% |
| 2005-12-31 | -37.27% |
| 2005-09-30 | -36.47% |
| 2005-06-30 | -33.88% |
| 2005-03-31 | -31.49% |
| 2004-12-31 | -27.68% |
| 2004-09-30 | -25.55% |
| 2004-06-30 | -23.40% |
| 2004-03-31 | -20.53% |
| 2003-12-31 | -19.13% |
| 2003-09-30 | -17.67% |
| 2003-06-30 | -16.94% |
